Eko Analysis Software vs ASSURE Wearable ECG
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your primary need is an FDA-cleared AI-powered diagnostic aid for the early detection of specific cardiovascular conditions like heart murmurs and atrial fibrillation during a clinical examination or remote auscultation. It is ideal for clinicians seeking to augment their auscultation skills with AI analysis, detailed phonocardiogram and ECG visualizations, and secure recording capabilities for review and collaboration.
View Eko Analysis Software →Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you require continuous, long-term heart rate and rhythm monitoring for at-risk cardiac patients to capture intermittent events and track physiological trends. This tool is best suited for remote patient monitoring programs where patient comfort, artifact reduction through advanced algorithms, and a comprehensive remote data platform for clinician review are critical.
View ASSURE Wearable ECG →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | ASSURE Wearable ECG |
|---|---|---|
| Pricing | Freemium with subscription for full features | Contact for pricing. |
| Deployment | Cloud-based | Wearable device, mobile application, and cloud-based remote patient data platform. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with familiar digital stethoscopes and a mobile app, offering a user-friendly interface for recording and visualizing heart sounds and ECGs. Its freemium model provides an accessible entry point for clinicians to explore basic features before committing to a subscription for advanced AI capabilities.
Clinical Value
ASSURE Wearable ECGWhile Eko provides valuable point-of-care AI-powered detection for murmurs and AFib, the ASSURE Wearable ECG system, as a Wearable Cardioverter Defibrillator (WCD), offers direct therapeutic intervention by automatically delivering defibrillating shocks for life-threatening ventricular arrhythmias. This capability provides a higher level of immediate clinical impact and patient protection for at-risk individuals.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software offers a transparent freemium model, allowing users to access basic features for free and clearly understand the cost of advanced AI-powered detection and reporting through a subscription. In contrast, ASSURE Wearable ECG requires contacting for pricing, which lacks transparency and can be a barrier to initial evaluation and adoption.
Enterprise Readiness
Eko Analysis SoftwareBoth tools are HIPAA compliant, offer BAAs, and are cloud-based, indicating readiness for enterprise deployment. However, Eko Analysis Software lists broader applicability across Cardiology, Emergency Medicine, and Internal Medicine, suggesting greater versatility and potential for integration across various departments within a healthcare enterprise.
Innovation
ASSURE Wearable ECGASSURE Wearable ECG demonstrates significant innovation through its 'SensorFit Garment' for comfortable continuous monitoring and 'Adaptive Patient Intelligence' with 'Quad Channel Processing' to effectively filter motion artifacts. This advanced engineering is crucial for reliable, high-quality long-term ECG data collection in real-world patient environments, which is a complex challenge in wearable technology.
Support & Docs
ASSURE Wearable ECGKestra Medical Technologies offers robust support for the ASSURE system, including a 24/7 ASSURE Helpline and crucial in-person training by Kestra Careu2122 specialists for proper device fitting and usage. This personalized, round-the-clock support is particularly valuable for a complex wearable medical device, ensuring optimal patient adherence and system operation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | ASSURE Wearable ECG |
|---|---|---|
| Name | Eko Analysis Software | ASSURE Wearable ECG |
| Company | Eko Devices | Kestra Medical Technologies |
| Primary Detection Capabilities | FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm; Calculation of cardiac time intervals (heart rate, QRS duration). | Continuous heart rate monitoring; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts; Automatic episode storage; Alert-based notifications. |
| Patient Data Platform/Storage | Secure cloud-based storage of recordings within the US; Recording, playback, and annotation of heart sounds and ECGs; Visualization of phonocardiograms (PCG) and ECG tracings. | Kestra CareStation remote patient data platform for clinician review; Physiologic trend data. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and ASSURE Wearable ECG.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Analysis Software or ASSURE Wearable ECG
Backers
Who funded each tool's parent company.